RTI Biologics Splits Chairman and CEO Roles

RTI Biologics Inc. RTIX announced today that the board of directors has separated the roles of chairman of the board and chief executive officer. Dean H. Bergy assumed the role of chairman of the board of directors effective May 5, 2011, while Brian K. Hutchison remains CEO of the company and a member of the board of directors. In conjunction with this change, the duties of the lead director have been transferred to the chairman position, and the lead director title, held by Peter F. Gearen, M.D. since July 2010, has been eliminated. Gearen remains a member of the board of directors.